Intervention of osteoclastogenesis that occurs in breast cancer and multiple myeloma

Uncommon genetic aberrations NTRK, RET, NRG

Updates on triple negative breast cancer and immunotherapy

Pembrolizumab combined with xelox and bevacizumab shows higher efficacy than standard therapeutic regimen in mCRC

Paclitaxel and ramucirumab switch maintenance therapy prolongs survival in HER2-negative advanced GEJ cancer

Glofit-GemOx shows clinically meaningful benefit in relapsed/refractory diffuse large B-cell lymphoma

TP53 mutations are linked to unfavourable prognosis in chronic lymphocytic leukaemia

Abemaciclib and fulvestrant show improved efficacy in HR+, HER2- advanced breast cancer compared to placebo and fulvestrant

A patient-reported questionnaire may eliminate the need for an ophthalmic exam before belantamab mafodotin dosing in TI NDMM

Novel CAR-T cell therapy shows promise against calreticulin mutant neoplasms

ASCO 2024: Lung cancer highlights

EHA 2024: Multiple myeloma roundup